Table 4.
Characteristics of patients who completed treatment versus those who lost follow-up
| Variables | Categories | Total | Completed followup n (%) | Lost to followup n (%) | P |
|---|---|---|---|---|---|
| Gender | Fem | 103 (28) | 76 (26.9) | 27 (31.8) | 0.377 |
| Masc | 265 (72) | 207 (73.1) | 58 (68.2) | ||
| Age (years) | 0–15 | 14 (3.8) | 6 (2.1) | 8 (9.4) | 0.014 |
| 16–29 | 135 (36.7) | 103 (36.4) | 32 (37.6) | ||
| 30–39 | 70 (19) | 58 (20.5) | 12 (14.1) | ||
| 40 | 149 (40.5) | 116 (41.0) | 33 (38.8) | ||
| Education (years of schooling) | 11 | 47 (12.8) | 38 (13.4) | 9 (10.6) | 0.461 |
| 8–10 | 73 (19.8) | 59 (20.8) | 14 (16.5) | ||
| <8 | 248 (67.4) | 186 (65.7) | 62 (72.9) | ||
| Clinical forms | BB | 82 (22.3) | 57 (20.1) | 25 (29.4) | 0.131 |
| BL | 123 (33.4) | 94 (33.2) | 29 (34.1) | ||
| LL | 163 (44.3) | 132 (46.6) | 31 (36.5) | ||
| Skin lesions | 15 | 72 (19.6) | 45 (16.0) | 27 (31.8) | 0.001 |
| >15 | 294 (79.9) | 236 (84.0) | 58 (68.2) | ||
| Initial bacillary index | 3 | 184 (50) | 137 (48.4) | 47 (55.3) | 0.266 |
| >3 | 184 (50) | 146 (51.6) | 38 (44.7) | ||
| Initial disability grade | 0 | 221 (60.1) | 169 (59.7) | 52 (61.2) | 0.934 |
| 1 | 104 (28.3) | 80 (28.3) | 24 (28.2) | ||
| 2 | 43 (11.7) | 34 (12.0) | 9 (10.6) | ||
| Cyanosis | Absent | 163 (44.3) | 122 (43.1) | 41 (48.2) | 0.404 |
| Present | 205 (55.7) | 161 (56.9) | 44 (51.8) | ||
| Edema | Absent | 176 (47.8) | 131 (46.3) | 45 (52.9) | 0.282 |
| Present | 192 (52.2) | 152 (53.7) | 40 (47.1) | ||
| Reversal reaction | No | 259 (70.4) | 194 (68.6) | 65 (76.5) | 0.161 |
| Yes | 109 (29.6) | 89 (31.4) | 20 (23.5) | ||
| ENL | No | 187 (50.8) | 137 (48.4) | 50 (58.8) | 0.092 |
| Yes | 181 (49.2) | 146 (51.6) | 35 (41.2) | ||
| Neuritis | No | 209 (56.8) | 155 (54.8) | 54 (63.5) | 0.151 |
| Yes | 159 (43.2) | 128 (45.2) | 31 (36.5) |